Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients

[1]  F. Buccisano,et al.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. , 2008, Blood.

[2]  Benjamin Haibe-Kains,et al.  Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. , 2007, Clinical chemistry.

[3]  J. Philippé,et al.  Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. , 2007, Clinical chemistry.

[4]  F. Menestrina,et al.  ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor , 2007, Leukemia.

[5]  S. Deaglio,et al.  In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. , 2006, Blood.

[6]  V. Gattei,et al.  ZAP‐70 expression in B‐cell chronic lymphocytic leukemia: Evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgVH mutations , 2006, Cytometry. Part B, Clinical cytometry.

[7]  B. Saka,et al.  Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. , 2006, Clinical and laboratory haematology.

[8]  W. Graveland,et al.  The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. , 2006, Haematologica.

[9]  S. Johnson,et al.  Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. , 2005, Clinical and laboratory haematology.

[10]  F. Davi,et al.  The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. , 2005, Blood.

[11]  H. Döhner,et al.  High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia , 2005, Leukemia.

[12]  Nikolaos Laoutaris,et al.  Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.

[13]  Arthur Weiss,et al.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[14]  Adrian Wiestner,et al.  ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.

[15]  Adrian Wiestner,et al.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.

[16]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[17]  G. Guida,et al.  The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. , 2003, Blood.

[18]  D. Oscier,et al.  Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.

[19]  H. Döhner,et al.  Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. , 2002, Blood.

[20]  Göran Roos,et al.  Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.

[21]  D. Oscier,et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.

[22]  Richard Greil,et al.  The Role of Soluble CD23 in Distinguishing Stable and Progressive Forms of B-chronic Lymphocytic Leukemia , 2002, Leukemia & lymphoma.

[23]  R. Bataille,et al.  CD38 expression and secondary 17p deletion are important 
prognostic factors in chronic lymphocytic leukaemia , 2002, British journal of haematology.

[24]  A. Domingo-Clarós,et al.  CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. , 2002, Haematologica.

[25]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[26]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[27]  K. Döhner,et al.  Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia , 1998, Annals of Hematology.

[28]  E. Thiel,et al.  Prognostic impact of the serum levels of soluble CD23 in B-cell chronic lymphocytic leukemia. , 1997, Blood.

[29]  H. Döhner,et al.  Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. , 1997, Leukemia.

[30]  S. Chevret,et al.  Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. , 1996, Blood.

[31]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[32]  C. Gasche,et al.  Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  S. Fournier,et al.  The Low‐Affinity Receptor for IgE , 1992, Immunological reviews.

[34]  R. Levy,et al.  Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. , 1992, Molecular immunology.

[35]  L. Lagneaux,et al.  Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. , 1988, Blood.

[36]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[37]  Ciril Rozman,et al.  Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance , 1986, British journal of haematology.